We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Mycenax Biotech Inc (4726) - Financial and Strategic SWOT Analysis Review

Published: March 2019
Pages: 25
Code: 4162C2A11A74162A8B23BBDB352050A2
Format: PDF
Publisher GlobalData
From Add to basket
$ 300.00
Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, and breast cancer and indications for treatment of patients undergoing chemotherapy. It provides services such as biopharmaceutical drug development, contract manufacturing, consultation, aseptic fill and finish, CTD support services and cell bank establishment, among others. Mycenax offers services such as upstream fermentation, downstream fermentation, sterile preparations production, regulatory and project management services. The company provides consultation services such as evaluation market and technical, project planning, project management, regulatory compliance and clinical project management, among others. Mycenax is headquartered in Zhunan, Taiwan.
Mycenax Biotech Inc Key Recent Developments
Sep 14,2018: 2018-09-14 Mycenax Biotech Inc. has been shortlisted as a finalist in the CPhI Pharma Awards![Company PR : Pharma - Mycenax Biotech Inc]
Sep 14,2018: Mycenax Biotech Inc. has been shortlisted as a finalist in the CPhI Pharma Awards!
Jul 04,2018: BIOtech Japan 2018 is completed and Mycenax display excellent strength
May 22,2018: Pearl Fong, Associate VP to give presentation in 9th Annual Biosimilars Asia
This comprehensive SWOT profile of Mycenax Biotech Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mycenax Biotech Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • Table of Contents
  • Section 1 - About the Company
  • Mycenax Biotech Inc - Key Information
  • Mycenax Biotech Inc - Overview
  • Mycenax Biotech Inc - Key Employees
  • Mycenax Biotech Inc - Key Employee Biographies
  • Mycenax Biotech Inc - Key Operational Heads
  • Mycenax Biotech Inc - Major Products and Services
  • Mycenax Biotech Inc - History
  • Mycenax Biotech Inc - Company Statement
  • Mycenax Biotech Inc - Locations And Subsidiaries
  • Mycenax Biotech Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Mycenax Biotech Inc - Business Description
  • Mycenax Biotech Inc - Corporate Strategy
  • Mycenax Biotech Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Mycenax Biotech Inc - Strengths
  • Mycenax Biotech Inc - Weaknesses
  • Mycenax Biotech Inc - Opportunities
  • Mycenax Biotech Inc - Threats
  • Mycenax Biotech Inc - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Mycenax Biotech Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company
  • List of Tables
  • Mycenax Biotech Inc, Key Information
  • Mycenax Biotech Inc, Key Ratios
  • Mycenax Biotech Inc, Share Data
  • Mycenax Biotech Inc, Major Products and Services
  • Mycenax Biotech Inc, History
  • Mycenax Biotech Inc, Key Employees
  • Mycenax Biotech Inc, Key Employee Biographies
  • Mycenax Biotech Inc, Key Operational Heads
  • Mycenax Biotech Inc, Other Locations
  • Mycenax Biotech Inc, Subsidiaries
  • Mycenax Biotech Inc, Key Manufacturing facilities
  • Mycenax Biotech Inc, Key Competitors
  • Mycenax Biotech Inc, SWOT Analysis
  • Mycenax Biotech Inc, Ratios based on current share price
  • Mycenax Biotech Inc, Annual Ratios
  • Mycenax Biotech Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Mycenax Biotech Inc, Performance Chart
  • Mycenax Biotech Inc, Ratio Charts